Biogen Begins Brain Contusion Study, Enrolls First Patient
NEW YORK, NY – October 22, 2019 – Embark Healthcare announced today that Biogen (Nasdaq:BIIB), an American multinational biotechnology company based in Cambridge, Massachusetts and specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide, reported that it enrolled the first patient in a phase 2 brain contusion […]
Biogen Begins Brain Contusion Study, Enrolls First Patient Read More »